There are good techniques today for controlling tumors in iPSCs. But, I agree. There should be done more research in future.The big issue here is cancer because basically they are reprogramming skin cells to turn into DP cells, the process is not efficient and the reprogrammed cells could end up being cancerous. This is the big issue with ips cells but apparently the risks can now be controlled and hence the long research needed so I would not get too excited, it's the standard 5-10 years scenario but I'm positive we will get there in the end with this kind of therapy.
For example:
Tumour resistance in induced pluripotent stem cells derived from naked mole-rats
https://www.nature.com/articles/ncomms11471
Last edited: